CR
Cronos Group Inc.
CRON · NASDAQ
$3.16 -0.63% (-$0.02)
1M +3.57%
Market Cap $1.18B
P/E Ratio 16.89x
Div. Yield -
ROE 6.46%
Bulios Fair Price
$2.08
34.1% downside
Trenutna cena
$3.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CRON trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
45 /100
Fair P/FCF 26.47x
P/E 16.89x
P/B 1.10x
Growth
82 /100
Growing Book val. growth 1.48%
Rev. growth 30.63%
FCF growth N/A
Profitability
69 /100
Strong Op. margin 5.12%
Gross margin 33.54%
FCF margin 18.34%
Quality
20 /100
Poor ROA 5.91%
ROIC 1.28%
Asset turnover 0.21x
Debt
100 /100
Low Net debt/EBITDA -19.12x
Debt/Equity 0.00x
Current ratio 16.18x
Stability
23 /100
Unstable EPS volatility 141.97%
Beta 1.24x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CRON
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Ryan Gorenstein
Employees
610
Headquarters
Stayner
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report